Chlamydia screening coverage estimates derived using healthcare effectiveness data and information system procedures and indirect estimation vary substantially

Sexually Transmitted Diseases

Volumn 40, Issue 4, 2013, Pages 292-297

  Broad, Jennifer M ^a   Manhart, Lisa E ^a   Kerani, Roxanne P ^b   Scholes, Delia ^c   Hughes, James P ^a   Golden, Matthew R ^a,b  

^a UNIVERSITY OF WASHINGTON   (United States)

^b Public Health Seattle and King County ^*  (United States)

^c GROUP HEALTH RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; ADULT; ARTICLE; CHLAMYDIA; CHLAMYDIASIS; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MEDICAL INFORMATION; POPULATION SIZE; REPEAT PROCEDURE; SCREENING; SEXUAL BEHAVIOR;

ADOLESCENT; ADULT; CHLAMYDIA INFECTIONS; CHLAMYDIA TRACHOMATIS; DATABASES, FACTUAL; FEMALE; HUMANS; INFORMATION SYSTEMS; MASS SCREENING; MODELS, THEORETICAL; REPRODUCIBILITY OF RESULTS; REPRODUCTIVE HEALTH SERVICES; SENTINEL SURVEILLANCE; STATISTICS AS TOPIC; WASHINGTON;

EID: 84875215300     PISSN: 01485717     EISSN: 15374521     Source Type: Journal    
DOI: 10.1097/OLQ.0b013e3182809776     Document Type: Article

References (30)

1. Scholes D, Stergachis A, Heidrich FE, et al. Prevention of pelvic inflammatory disease by screening for cervical chlamydial infection. N Engl J Med 1996; 334: 1362-1366.
2. Ostergaard L, Andersen B, Moller JK, et al. Home sampling versus conventional swab sampling for screening of Chlamydia trachomatis in women: A cluster-randomized 1-year follow-up study. Clin Infect Dis 2000; 31: 951-957.
3. Oakeshott P, Kerry S, Aghaizu A, et al. Randomised controlled trial of screening for Chlamydia trachomatis to prevent pelvic inflammatory disease: The POPI (Prevention of Pelvic Infection) trial. BMJ 2010; 340: c1642.
4. Kretzschmar M, Welte R, van den Hoek A, et al. Comparative modelbased analysis of screening programs for Chlamydia trachomatis infections. Am J Epidemiol 2001; 153: 90-101.
5. Turner KM, Adams EJ, Lamontagne DS, et al. Modelling the effectiveness of chlamydia screening in England. Sex Transm Infect 2006; 82: 496-502.
6. Low N, McCarthy A, Macleod J, et al. Epidemiological, social, diagnostic and economic evaluation of population screening for genital chlamydial infection. Health Technol Assess 2007; 11: iiiY iv, ixYxii, 1-165.
7. Althaus CL, Heijne JC, Roellin A, et al. Transmission dynamics of Chlamydia trachomatis affect the impact of screening programmes. Epidemics 2010; 2: 123-131.
8. Regan DG, Wilson DP, Hocking JS. Coverage is the key for effective screening of Chlamydia trachomatis in Australia. J Infect Dis 2008; 198: 349-358.
9. Ray MN, Wall T, Casebeer L, et al. Chlamydia screening of atrisk young women in managed health care: Characteristics of topperforming primary care offices. Sex Transm Dis 2005; 32: 382-386.
10. Centers for Disease Control and Prevention (CDC). Chlamydia screening among sexually active young female enrollees of health plansVUnited States, 2000-2007. MMWR Morb Mortal Wkly Rep 2009; 58: 362-365.
11. Shih SC, Bost JE, Pawlson LG. Standardized health plan reporting in four areas of preventive health care. Am J Prev Med 2003; 24: 293-300.
12. Mangione-Smith R, McGlynn EA, Hiatt L. Screening for chlamydia in adolescents and young women. Arch Pediatr Adolesc Med 2000; 154: 1108-1113.
13. Wei F, Walsh CM. Validation of data collection for the HEDIS performance measure on chlamydia screening in an MCO. Am J Manag Care 2003; 9: 585-593.
14. Centers for Disease Control and Prevention (CDC). CDC Grand Rounds: Chlamydia prevention: Challenges and strategies for reducing disease burden and sequelae. MMWR Morb Mortal Wkly Rep 2011; 60: 370-373.
15. National Committee for Quality Assurance. The State of Health Care Quality.Washington, DC: National Committee for Quality Assurance, 2010.
16. Tao G, Walsh CM, Anderson LA, et al. Understanding sexual activity defined in the HEDIS measure of screening young women for Chlamydia trachomatis. Jt Comm J Qual Improv 2002; 28: 435-440.
17. Levine WC, Dicker LW, Devine O, et al. Indirect estimation of Chlamydia screening coverage using public health surveillance data. Am J Epidemiol 2004; 160: 91-96.
18. Tao G, Tian LH, Peterman TA. Estimating chlamydia screening rates by using reported sexually transmitted disease tests for sexually active women aged 16 to 25 years in the United States. Sex Transm Dis 2007; 34: 180-182.
19. Meyers DS, Halvorson H, Luckhaupt S. Screening for chlamydial infection: An evidence update for the U.S. Preventive Services Task Force. Ann Intern Med 2007; 147: 135-142.
20. Workowski KA, Berman SM. Sexually transmitted diseases treatment guidelines, 2006. MMWR Recomm Rep 2006; 55: 1-94.
21. Scholes D, Satterwhite CL, Yu O, et al. Long-term trends in Chlamydia trachomatis infections and related outcomes in a U.S. managed care population. Sex Transm Dis 2012; 39: 81-88.
22. National Committee for Quality Assurance. HEDIS Effectiveness of Care 2010, Prevention and Screening. Washington, DC: National Committee for Quality Assurance, 2009: 31-34.
23. Lepkowski J, Mosher W, Davis K, et al. The 2006-2010 National Survey of Family Growth: Sample Design and Analysis of a Continuous Survey. Vital Health Stat. Vol. 2. Hyattsville, MD: National Center for Health Statistics, 2010.
24. Abma J, Martinez G, Copen C. Teenagers in the United States: Sexual Activity, Contraceptive Use, and Childbearing, National Survey of Family Growth 2006-2008. Vital Health Stat. Vol. 23. Hyattsville, MD: National Center for Health Statistics, 2010.
25. Low N. Screening programmes for chlamydial infection: when will we ever learn? BMJ 2007; 334: 725-728.
26. Low N. Current status of chlamydia screening in Europe. Euro Surveill 2004; 8: 5.
27. Op de Coul EL, Gotz HM, van Bergen JE, et al. Who participates in the Dutch chlamydia screening? A study on demographic and behavioral correlates of participation and positivity. Sex Transm Dis 2012; 39: 97-103.
28. Sheringham J, Simms I, Riha J, et al. Will chlamydia screening reach young people in deprived areas in England? Baseline analysis of the English National Chlamydia Screening Programme delivery in 2008. Sex Transm Dis 2011; 38: 677-684.
29. Smith RA, Cokkinides V, Brooks D, et al. Cancer screening in the United States, 2011: A review of current American Cancer Society guidelines and issues in cancer screening. CA Cancer J Clin 2011; 61: 8-30.
30. Datta SD, Torrone E, Kruszon-Moran D, et al. Chlamydia trachomatis trends in the United States among persons 14 to 39 years of age, 1999-2008. Sex Transm Dis 2012; 39: 92-96.